Cargando…
Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19
We present a female kidney transplant patient under conventional immunosuppression therapy. Her humoral immunity study (anti-spike-specific antibodies) was negative after the initial regimen and the third dose of vaccination against COVID-19. The specific ex vivo cellular immune study against spike...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748959/ https://www.ncbi.nlm.nih.gov/pubmed/36524267 http://dx.doi.org/10.1136/bcr-2022-250509 |
_version_ | 1784849938667012096 |
---|---|
author | Barrios, Yvelise Alava-Cruz, Cristina Marrero-Miranda, Domingo Matheu, Victor |
author_facet | Barrios, Yvelise Alava-Cruz, Cristina Marrero-Miranda, Domingo Matheu, Victor |
author_sort | Barrios, Yvelise |
collection | PubMed |
description | We present a female kidney transplant patient under conventional immunosuppression therapy. Her humoral immunity study (anti-spike-specific antibodies) was negative after the initial regimen and the third dose of vaccination against COVID-19. The specific ex vivo cellular immune study against spike of SARS-CoV-2 by interferon gamma release assay (IGRA) also remained at non-response levels at different time points despite an optimal non-specific cell immune response assessment. However, the cellular immunity test by delayed-type hypersensitivity (DTH) with spike of SARS-CoV-2 was always positive since the vaccination scheme began. Only after COVID-19 infection has there been a seroconversion of the patient’s antibody tests along with IGRA positivity. The use of DTH test to measure the immune response could be a better and earlier parameter of the actual immune status that helps us to predict the immune response in real life. Hybrid immunity combining vaccine and natural infection could be a stronger stimulator of the specific global immune response. |
format | Online Article Text |
id | pubmed-9748959 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-97489592022-12-15 Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 Barrios, Yvelise Alava-Cruz, Cristina Marrero-Miranda, Domingo Matheu, Victor BMJ Case Rep Case Reports: Novel diagnostic procedure We present a female kidney transplant patient under conventional immunosuppression therapy. Her humoral immunity study (anti-spike-specific antibodies) was negative after the initial regimen and the third dose of vaccination against COVID-19. The specific ex vivo cellular immune study against spike of SARS-CoV-2 by interferon gamma release assay (IGRA) also remained at non-response levels at different time points despite an optimal non-specific cell immune response assessment. However, the cellular immunity test by delayed-type hypersensitivity (DTH) with spike of SARS-CoV-2 was always positive since the vaccination scheme began. Only after COVID-19 infection has there been a seroconversion of the patient’s antibody tests along with IGRA positivity. The use of DTH test to measure the immune response could be a better and earlier parameter of the actual immune status that helps us to predict the immune response in real life. Hybrid immunity combining vaccine and natural infection could be a stronger stimulator of the specific global immune response. BMJ Publishing Group 2022-12-13 /pmc/articles/PMC9748959/ /pubmed/36524267 http://dx.doi.org/10.1136/bcr-2022-250509 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Reports: Novel diagnostic procedure Barrios, Yvelise Alava-Cruz, Cristina Marrero-Miranda, Domingo Matheu, Victor Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title | Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title_full | Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title_fullStr | Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title_full_unstemmed | Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title_short | Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19 |
title_sort | early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against covid-19 |
topic | Case Reports: Novel diagnostic procedure |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748959/ https://www.ncbi.nlm.nih.gov/pubmed/36524267 http://dx.doi.org/10.1136/bcr-2022-250509 |
work_keys_str_mv | AT barriosyvelise earlyriserspecificimmunecellresponsebydelayedtypehypersensitivityinakidneytransplantpatientvaccinatedagainstcovid19 AT alavacruzcristina earlyriserspecificimmunecellresponsebydelayedtypehypersensitivityinakidneytransplantpatientvaccinatedagainstcovid19 AT marreromirandadomingo earlyriserspecificimmunecellresponsebydelayedtypehypersensitivityinakidneytransplantpatientvaccinatedagainstcovid19 AT matheuvictor earlyriserspecificimmunecellresponsebydelayedtypehypersensitivityinakidneytransplantpatientvaccinatedagainstcovid19 |